Key result
Review examines rhythm control strategies, drug limitations, and ablation utility in AF and HF.
Why the study?
Nonpharmacological interventions likely alter the risks and benefits associated with rhythm control in patients with concomitant atrial fibrillation and heart failure.
Review highlights the effects of rhythm control strategies in heart failure patients with atrial fibrillation, suggesting important implications.
Because nonpharmacological interventions likely alter the risks and benefits associated with rhythm control, this paper reviews the role of current rhythm control strategies in atrial fibrillation. This report also focuses on the specific limitations of pharmacological interventions and the utility of percutaneous ablation in this growing population of patients with concomitant atrial fibrillation and heart failure.
No takes yet. Share an insight, caveat, or question.
Trulock et al. (2014) conducted a review in Atrial fibrillation and heart failure. Rhythm control strategies was evaluated. This review discusses the role of current rhythm control strategies, limitations of pharmacological interventions, and the utility of percutaneous ablation in patients with atrial fibrillation and heart failure.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: